Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00186641 · ClinicalTrials.gov registry record · Phase 2
High Dose Chemotherapy and Autologous Transplant for Breast Cancer
A Phase 2 study, sponsored by Stanford University.
- Completed
- Registry status
- Phase 2
- Development phase
- 203
- Enrollment target
NCT00186641: Completed Phase 2 study, sponsored by Stanford University.
NCT00186641 is a Phase 2 study that has completed, run by Stanford University. The registered enrollment target is 203 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00186641, a Phase 2 study, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 203 participants
- Enrollment target
Study Summary
To determine survival outcomes for patients with chemosensitive brest cancer after treatment with high dose chemotherapy
Interventions
- PROCEDURE high dose chemo and auto hematopoietic cell transplant
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 203 participants |
| Est. Completion | 2008-02-08 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00186641
The ClinicalTrials.gov registry entry for NCT00186641 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 203 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which high dose chemo and auto hematopoietic cell transplant is the first listed.
NCT00186641 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00186641 about?
NCT00186641 is a clinical study titled "High Dose Chemotherapy and Autologous Transplant for Breast Cancer". To determine survival outcomes for patients with chemosensitive brest cancer after treatment with high dose chemotherapy
What is the current status of trial NCT00186641?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 203 participants. Estimated completion is 2008-02-08.
What interventions are being tested in trial NCT00186641?
The interventions under investigation include: high dose chemo and auto hematopoietic cell transplant (PROCEDURE).
Who is sponsoring clinical trial NCT00186641?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.